first
smallpox
vaccin
conduct
edward
jenner
demonstr
inocul
materi
collect
lesion
milkmaid
suffer
cowpox
abl
protect
human
smallpox
landmark
moment
vaccin
histori
sinc
virul
viru
one
speci
abl
protect
anoth
speci
clinic
manifest
caus
differ
viru
potenti
fatal
addit
rabi
vaccin
first
viru
deliber
attenu
laboratori
order
creat
weaken
vaccin
viru
human
next
breakthrough
vaccin
product
came
mass
product
vaccin
viru
achiev
adapt
vitro
prepar
use
chicken
embryo
tissu
cultur
cell
vaccin
biolog
prepar
made
kill
attenu
pathogen
upon
administr
elicit
specif
adapt
immun
target
pathogen
given
vaccin
caus
sever
diseas
stimul
immun
system
vaccin
host
bodi
immun
system
recogn
pathogen
destroy
infect
occur
later
vaccin
constitut
highli
costeffect
measur
prevent
reduc
clinic
sign
infect
erad
infecti
diseas
compar
cost
chemotherapi
prophylaxi
mani
infecti
diseas
prevent
vaccin
although
rel
similar
anim
human
infecti
diseas
pathogenesi
outcom
deriv
vaccin
howev
ultim
goal
vaccin
industri
anim
definit
differ
human
vaccin
differ
due
variou
factor
type
anim
vaccin
desir
outcom
vaccin
cost
vaccin
econom
benefit
earn
vaccin
kind
infecti
agent
control
instanc
purpos
vaccin
industri
anim
mainli
enhanc
product
profit
livestock
produc
wherea
vaccin
companion
anim
would
aim
welfar
prevent
particular
infecti
diseas
similar
human
addit
vaccin
wildlif
appli
block
transmiss
zoonot
diseas
prone
spread
industri
anim
human
case
vaccin
zoonot
diseas
livestock
would
expect
reduc
remov
risk
transmiss
diseas
consum
well
protect
industri
anim
interestingli
addit
benefit
result
applic
vaccin
industri
anim
reduct
chemotherapi
industri
anim
subsequ
reduct
residu
meat
product
contribut
human
public
safeti
fact
grow
evid
largescal
nontherapeut
use
antibiot
livestock
product
associ
emerg
antibiot
resist
bacteria
industri
anim
problem
promot
use
vaccin
rather
chemotherapi
vaccin
would
prevent
diseas
anim
treatment
cure
may
result
antibiot
resist
pharmaceut
residu
food
note
use
antibiot
industri
anim
serious
restrict
eu
korea
moreov
new
guidelin
nontherapeut
use
antibiot
livestock
recent
establish
usa
gener
vaccin
produc
sever
differ
method
includ
inactiv
attenu
pathogen
alter
hostspecif
pathogen
use
immunogen
compon
alon
insert
gene
interest
carrier
vehicl
deliv
express
product
viruslik
particl
vlp
without
specif
genet
materi
interestingli
overwhelm
advantag
develop
anim
vaccin
contrast
human
vaccin
develop
one
evid
advantag
rel
low
cost
conduct
research
develop
anim
vaccin
compar
human
vaccin
addit
less
regul
develop
anim
vaccin
clinic
trial
human
vaccin
sinc
clinic
trial
anim
vaccin
allow
without
preclin
phase
mandatori
step
develop
human
vaccin
consequ
final
anim
vaccin
product
readili
commerci
within
short
period
time
nevertheless
smaller
profit
sector
anim
vaccin
anticip
due
lower
price
product
smaller
market
unlik
human
vaccin
industri
anim
vaccin
current
account
less
one
fourth
global
market
anim
health
product
howev
vaccin
product
industri
steadili
grown
increas
demand
new
anim
vaccin
variou
pathogen
reemerg
industri
anim
accordingli
number
licens
anim
vaccin
livestock
companion
anim
increas
decad
make
new
anim
vaccin
success
market
variou
factor
consid
comprehens
research
analysi
particular
diseas
includ
demand
commerci
product
region
demand
global
prospect
market
vaccin
virtu
greatli
advanc
molecular
techniqu
avail
great
deal
genom
inform
variou
pathogen
new
opportun
creat
novel
concept
vaccin
present
articl
address
briefli
variou
type
anim
vaccin
section
along
current
research
activ
anim
vaccin
conduct
korea
although
live
viral
vaccin
produc
sever
way
common
method
creat
vaccin
strain
made
pass
virus
cell
cultur
embryo
suitabl
materi
instanc
select
viru
strain
serial
pass
chicken
embryo
result
better
replic
chick
cell
lost
abil
replic
anim
cell
target
host
also
live
vaccin
virus
gener
induc
random
mutat
viral
genom
follow
select
nonvirul
mutant
incap
caus
clinic
diseas
altern
creat
attenu
viral
strain
virus
serial
pass
nonadapt
host
effect
propag
loss
pathogen
origin
host
confirm
method
involv
pass
viru
suitabl
matter
creat
new
version
viru
still
recogn
anim
immun
system
replic
well
vaccin
host
produc
necessari
immun
respons
host
host
challeng
infect
origin
pathogen
viru
importantli
protect
efficaci
deriv
live
attenu
vaccin
typic
outlast
provid
kill
inactiv
vaccin
nevertheless
vaccin
still
residu
virul
risk
revers
virul
phenotyp
singl
point
mutat
certain
gene
may
tend
induc
attenu
viru
may
lead
back
mutat
result
wild
type
virul
viru
consid
rel
high
mutat
rate
rna
virus
taken
consider
live
vaccin
virus
would
need
multipl
mutat
variou
gene
viral
genom
develop
attenu
vaccin
strain
despit
drawback
live
vaccin
live
vaccin
play
import
role
prevent
erad
viral
diseas
industri
anim
interestingli
potent
adjuv
necessari
formul
live
vaccin
live
vaccin
virus
capabl
infect
target
cell
provok
immun
respons
inject
virus
addit
live
vaccin
easili
administ
variou
rout
inject
drinkabl
water
instil
nasal
caviti
eye
exampl
modifi
live
vaccin
avian
influenza
viru
aiv
use
mani
countri
control
aiv
infect
sinc
kill
vaccin
moder
effect
multipl
inject
need
develop
protect
immun
although
vaccin
perfect
would
promis
control
mean
low
pathogen
avian
influenza
lpai
date
porcin
epidem
diarrhea
viru
pedv
agent
caus
sever
enteropathogen
diarrhea
pig
lead
signific
econom
loss
asia
pedv
strain
field
isol
attenu
serial
pass
viru
vero
cell
test
virul
piglet
sow
vero
celladapt
viru
show
reduc
pathogen
induc
protect
immun
pig
indic
attenu
viru
may
vaccin
candid
inactiv
vaccin
safer
live
vaccin
replic
vaccin
host
result
risk
revers
virul
form
capabl
caus
diseas
howev
gener
provid
shorter
length
protect
live
vaccin
gener
elicit
weak
immun
respons
particular
cellmedi
immun
oppos
live
viral
vaccin
reason
inactiv
vaccin
administ
potent
adjuv
requir
booster
elicit
satisfactori
longterm
immun
vaccin
type
gener
creat
inactiv
propag
virus
treatment
heat
chemic
formalin
binari
ethyleneimin
procedur
destroy
pathogen
abil
propag
vaccin
host
keep
intact
immun
system
still
recogn
although
inactiv
viru
vaccin
use
prevent
variou
type
viral
diseas
decad
need
develop
control
newli
emerg
diseas
exampl
influenza
viru
vaccin
continu
improv
contain
serotyp
mani
new
serotyp
emerg
new
outbreak
approach
mani
studi
focus
search
better
adjuv
enhanc
immun
respons
accord
inactiv
vaccin
well
help
overcom
inhibitori
effect
matern
antibodi
live
aiv
vaccin
possibl
reassort
live
vaccin
strain
field
isol
back
mutat
lowpathogen
highli
pathogen
virus
lead
seriou
concern
vaccin
safeti
thu
prior
stimul
immun
system
use
immunomodul
follow
vaccin
inactiv
vaccin
may
need
confer
better
protect
immun
within
short
period
time
may
promis
control
lpai
subunit
vaccin
classifi
type
inactiv
vaccin
contain
part
viru
microorgan
subunit
vaccin
pathogen
gener
recombin
protein
variou
express
system
long
appropri
immunogen
antigen
target
pathogen
empir
determin
recombin
protein
compon
safe
nonrepl
subunit
vaccin
manipul
dna
encod
protein
larg
quantiti
protein
express
purifi
immun
target
host
order
stimul
immun
reaction
pathogen
gener
vaccin
antigen
alon
elicit
weak
immun
respons
potent
adjuv
repeat
vaccin
requir
high
cost
produc
subunit
vaccin
would
deterior
competit
vaccin
product
compar
type
vaccin
despit
limit
sever
subunit
vaccin
launch
market
anoth
type
subunit
vaccin
creat
via
genet
engin
gene
encod
immunogen
antigen
insert
anoth
carrier
viru
produc
cell
cultur
system
carrier
viru
propag
produc
cell
metabol
insert
gene
also
express
releas
cytoplasm
end
result
approach
recombin
vaccin
immun
system
vaccin
host
recogn
express
protein
provid
futur
protect
target
viru
exampl
open
read
frame
protein
porcin
circoviru
type
major
agent
respons
develop
postwean
multisystem
wast
syndrom
pig
recent
produc
baculoviru
express
system
subunit
vaccin
contain
protein
commerci
vaccin
purchas
distribut
pig
farm
govern
sinc
signific
econom
loss
three
year
ago
usd
million
annual
requir
purchas
vaccin
intern
pharmaceut
compani
govern
signific
market
share
follow
korean
vaccin
compani
meanwhil
subunit
vaccin
capabl
prevent
newcastl
diseas
viru
ndv
poultri
success
regist
hemagglutininneuraminidas
hn
protein
protect
antigen
ndv
produc
plant
cell
demonstr
protect
vaccin
chicken
challeng
wild
type
viru
also
fusion
f
hn
protein
deriv
ndv
isol
la
sota
strain
ndv
express
purifi
use
subunit
vaccin
subunit
vaccin
reduc
significantli
amount
viral
shed
singl
applic
footandmouth
diseas
viru
fmdv
structur
protein
involv
neutral
viru
wherea
rnadepend
rna
polymeras
highli
conserv
among
serotyp
strongli
immunogen
recombin
protein
induc
antigenspecif
immun
respons
indic
subunit
vaccin
candid
fmdv
premembran
prm
envelop
e
protein
japanes
enceph
jev
express
insect
cell
immunogen
recombin
prm
e
protein
demonstr
complet
protect
mice
virul
viru
challeng
provid
valuabl
inform
develop
efficaci
subunit
vaccin
jev
deliveri
vehicl
nonpathogen
live
viru
carri
foreign
dna
administ
host
creat
proper
immun
insert
protein
live
deliveri
viru
inject
gene
interest
introduc
within
vector
vehicl
express
vaccin
host
host
elicit
immun
respons
express
protein
immun
respons
express
protein
carri
vehicl
viru
would
follow
natur
immun
stimulatori
pathway
interestingli
hostrestrict
vector
viru
replic
within
tissu
vaccin
anim
abl
temporarili
express
foreign
protein
vaccin
free
advers
effect
stabl
nonadjuv
allow
differenti
infect
vaccin
anim
diva
approv
vehicl
virus
current
use
sever
veterinari
diseas
includ
adenoviru
fowl
pox
yellow
fever
vaccinia
viru
among
poxvirus
wide
use
deliveri
vaccin
antigen
due
abil
accommod
larg
amount
exogen
gene
infect
variou
type
mammalian
cell
well
express
high
level
protein
replic
mammalian
cell
even
though
genom
delet
particular
fowl
pox
canari
pox
viru
hostrestrict
advantag
compar
vaccin
virus
even
though
recombin
canari
pox
viru
show
abort
infect
mammalian
cell
thu
poorli
replic
host
effect
express
insert
gene
consequ
anim
vaccin
develop
use
system
instanc
rabi
vaccin
prototyp
vector
vaccin
current
use
sever
countri
oral
cowpoxrabi
bait
vaccin
contain
g
glycoprotein
protect
antigen
rabi
viru
abl
prevent
rabi
wild
carnivor
fox
raccoon
coyot
recombin
vaccinia
viru
contain
gene
encod
glycoprotein
rabi
viru
abl
administ
mani
type
wildlif
order
protect
rabi
use
eu
north
america
korea
interestingli
vaccin
use
diva
vaccin
sinc
fowl
vaccin
viru
form
antibodi
matrix
protein
nucleoprotein
exampl
haemagglutinin
ha
gene
influenza
viru
incorpor
within
genedelet
vaccin
strain
fowl
pox
provok
immun
respons
ha
protein
vaccin
chicken
result
protect
diseas
vaccin
shown
effect
field
morbid
shed
influenza
viru
use
primari
vaccin
administr
replicationincompet
glycoprotein
bexpress
adenoviru
induc
humor
cellular
immun
respons
provid
effect
protect
virul
pseudorabi
challeng
convent
vaccin
develop
primarili
control
diseas
anim
upon
infect
pathogen
microorgan
vaccin
increasingli
assess
abil
reduc
viru
transmiss
thu
establish
herd
immun
howev
control
erad
anim
viral
diseas
vaccin
prevent
diseas
also
reduc
transmiss
viru
one
anim
anoth
transmiss
viru
suffici
reduc
vaccin
given
viru
eventu
erad
defin
popul
marker
vaccin
construct
allow
infect
anim
distinguish
vaccin
anim
companion
diagnost
techniqu
appli
new
concept
vaccin
diva
vaccin
establish
describ
vaccin
carri
least
one
antigen
protein
less
correspond
wild
type
viru
diva
vaccin
unabl
produc
antibodi
protein
delet
gene
wild
type
viru
invok
antibodi
protein
antibodi
differenti
use
proper
diagnost
techniqu
type
vaccin
infect
anim
carri
wild
type
viru
identifi
vaccin
anim
diagnost
tool
use
monitor
transmiss
wild
type
viru
popul
vaccin
diva
vaccin
type
vaccin
activ
develop
sinc
genet
manipul
pathogen
easili
achiev
great
advanc
techniqu
addit
diva
vaccin
cut
edg
vaccin
develop
sinc
includ
delet
gene
respons
virul
way
revert
virul
wild
type
vaccin
anim
first
diva
vaccin
use
differ
infect
vaccin
pig
pseudorabi
demonstr
vaccin
reduc
transmiss
wild
type
viru
popul
result
shorten
durat
viru
shed
pig
upon
experiment
challeng
infect
bovin
herpesviru
type
vaccinationchalleng
experi
live
inactiv
glycoprotein
eneg
diva
vaccin
glycoprotein
dsubunit
diva
vaccin
demonstr
reduc
viru
shed
intranas
challeng
classic
swine
fever
csf
signific
contagi
swine
diseas
world
attenu
csf
vaccin
use
countri
diseas
enzoot
outbreak
use
csf
free
countri
subunit
vaccin
compos
ge
produc
baculoviru
express
system
along
discriminatori
enzymelink
immunosorb
assay
elisa
diva
vaccin
use
emerg
vaccin
area
csf
newli
develop
extens
use
field
anoth
strategi
util
countri
vaccin
pig
outbreak
switch
live
subunit
vaccin
complet
stop
vaccin
strategi
would
appli
korea
may
adopt
futur
world
health
organis
anim
health
may
could
announc
countri
use
live
vaccin
without
outbreak
may
recogn
csffree
countri
potenti
diva
vaccin
csf
viru
csfv
gedelet
pseudorabi
viru
vector
express
subunit
csfv
vaccin
prevent
transmiss
challeng
csfv
pig
contact
vaccin
challeng
pig
differenti
infect
vaccin
pig
probabl
base
companion
diagnost
test
detect
antibodi
viral
protein
e
case
herp
viru
thymidin
kinas
tk
delet
viru
abl
infect
neuron
replic
caus
diseas
sinc
herp
viru
requir
tk
return
latenc
vaccin
confer
effect
protect
block
cell
invas
virul
viru
prevent
establish
persist
carrier
statu
genedelet
vaccin
aujeszki
diseas
ad
use
korea
us
part
eu
contribut
erad
ad
diva
concept
use
veterinari
vaccin
may
prove
import
use
strategi
futur
develop
human
vaccin
exampl
immunogen
vlp
vaccin
express
ha
protein
aiv
immun
chicken
measur
elisa
use
express
nucleocapsid
antigen
sinc
protein
carri
surfac
vlp
vaccin
show
differenti
aivinfect
chicken
vaccin
one
nonstructur
protein
west
nile
viru
wnv
reliabl
indic
past
infect
anim
elisa
use
monoclon
antibodi
express
demonstr
capabl
differenti
wild
type
viru
infect
anim
anim
vaccin
kill
wnv
vaccin
would
consid
potenti
diva
mean
capabl
monitor
wnv
transmiss
vlp
vaccin
highli
pathogen
avian
influenza
hpai
recent
construct
immun
specif
pathogen
free
chicken
vaccin
induc
high
level
haemagglutin
neuraminidas
inhibit
vaccin
chicken
compar
control
group
furthermor
possibl
differenti
vlpvaccin
chicken
infect
one
use
commerci
elisa
kit
rich
inform
avail
viral
genom
along
advanc
avail
genet
tool
scientist
abl
deliber
manipul
viral
genet
materi
order
creat
attenu
live
inactiv
virus
one
great
advanc
field
abil
creat
infecti
clone
contain
full
viral
genom
sequenc
bacteri
plasmid
viral
gene
infecti
clone
easili
manipul
transfect
suscept
cell
order
engin
genet
manipul
viru
techniqu
chimer
viru
shuffl
differ
viral
genom
gener
desir
outcom
howev
concern
viru
may
becom
recombin
field
strain
consequ
pathogen
may
restor
exampl
tkdelet
bhv
vaccin
potenti
infecti
found
latent
safeti
issu
suggest
delet
multipl
gene
enhanc
stabil
genet
modifi
virus
chimer
circoviru
type
vaccin
develop
insert
immunogen
capsid
gene
circoviru
type
backbon
nonpathogen
circoviru
type
result
protect
pig
challeng
virul
circoviru
type
use
reversegenet
bival
vaccin
express
h
n
gene
differ
aiv
construct
singl
ndv
background
chimer
viru
abl
form
strong
immun
field
influenza
ndv
concept
also
adapt
develop
aiv
vaccin
gene
deriv
viru
modifi
delet
polybas
amino
acid
combin
gene
viru
recombin
gene
introduc
backbon
genom
recombin
viru
express
protein
deriv
strain
provid
protect
chicken
duck
hpai
viru
strain
vaccin
licens
asian
countri
includ
korea
concept
expand
develop
vaccin
sever
viral
diseas
genom
virul
porcin
reproduct
respiratori
syndrom
viru
prrsv
major
agent
caus
devast
diseas
swine
industri
reversegenet
engin
plasmid
dna
form
infecti
clone
genom
alter
posit
chang
glycosyl
deglycosyl
result
epitop
trigger
neutral
antibodi
experiment
vaccin
known
produc
high
titer
neutral
antibodi
even
wild
type
viru
well
doubl
mutant
viru
suggest
crossprotect
may
occur
high
titer
antibodi
strategi
support
evid
doubl
mutant
chimer
viru
us
strain
korean
lmi
strain
construct
reproduc
immun
respons
laboratori
nake
dnabas
immun
becom
rel
novel
approach
develop
vaccin
sinc
concept
report
dna
vaccin
sinc
produc
varieti
diseas
test
laboratori
consider
success
success
elicit
effici
immun
antigen
encod
introduc
genet
materi
offer
potenti
advanc
product
effect
vaccin
sinc
gene
interest
clone
plasmid
vector
capabl
express
protect
antigen
immun
anim
absenc
intact
antigen
problem
associ
revers
virul
minim
addit
dna
vaccin
induc
strong
immun
confer
long
last
immun
associ
memori
cell
varieti
bacteria
parasit
mark
progress
recombin
dna
techniqu
past
decad
made
possibl
gener
varieti
dna
vaccin
variou
type
infecti
agent
recent
year
dna
vaccin
becom
one
promis
strategi
develop
safe
effici
altern
vaccin
particular
target
highli
virul
viral
diseas
advanc
procedur
enhanc
immun
respons
produc
dna
vaccin
recent
achiev
target
desir
antigen
specif
antigen
present
cell
apc
altern
mani
attenu
bacteria
specif
target
apc
respons
immun
reaction
design
locat
suggest
use
specif
deliv
dna
specif
loci
bacteri
vector
includ
attenu
strain
shigella
listeria
salmonella
express
recombin
antigen
control
eukaryot
promot
unlik
recombin
protein
vaccin
alon
recombin
vector
vaccin
result
highli
immunogen
respons
foreign
protein
vaccin
retain
advantag
associ
use
live
vector
immunogen
ensur
deliveri
antigen
nativ
conform
without
mani
safeti
concern
associ
liveattenu
vector
immun
dna
vaccin
vaccin
approach
wide
investig
protect
larg
number
infecti
diseas
exampl
gene
fmdv
carri
critic
epitop
induc
immun
respons
neutral
fmdv
dna
vaccin
contain
epitop
fmdv
abil
elicit
fmdv
specif
cell
prolifer
neutral
antibodi
fmd
swine
dna
vaccin
contain
infecti
bursal
diseas
viru
ibdv
acut
highli
contagi
diseas
chicken
shown
exhibit
higher
surviv
rate
low
bursal
atrophi
compar
nonimmun
group
challeng
immun
deriv
dna
vaccin
seem
contribut
high
level
protect
immun
overal
protect
chicken
ibdv
plasmid
dna
contain
gd
gene
aujeszki
diseas
viru
adv
elicit
serum
neutral
antibodi
week
immun
indic
may
dna
vaccin
candid
adv
administr
dna
vaccin
contain
gene
sever
acut
respiratori
syndrom
sar
lifethreaten
highli
emerg
diseas
elicit
signific
level
antibodi
respons
vaccin
mice
potenti
dna
vaccin
candid
sar
replic
viru
eukaryot
cell
viru
uniqu
characterist
selfassembl
particl
characterist
make
possibl
gener
vlp
cell
cultur
system
vlp
differenti
live
attenu
viru
lack
product
viral
infect
nonrepl
nonpathogen
mimic
viru
particl
vlp
vaccin
recogn
rel
new
concept
vaccin
develop
sinc
genet
materi
requir
form
vlp
drawback
shown
vaccin
strategi
observ
includ
virul
revers
accident
mutat
spontan
reassort
mammalian
immun
system
highli
attun
recogn
attack
vlp
follow
inject
sinc
conform
similar
vlp
infecti
virion
consider
low
quantiti
vlp
antigen
suffici
provok
similar
protect
immun
addit
vlp
shown
highli
effect
stimul
cell
prolifer
cytotox
lymphocyt
respons
use
vlp
would
promis
vaccin
strategi
varieti
virus
sinc
elicit
high
titer
longliv
immun
divers
virus
date
vlp
produc
differ
virus
infect
human
anim
howev
virus
applic
form
vlp
vaccin
sinc
conform
structur
viru
variabl
compos
either
singl
multipl
capsid
without
lipid
envelop
major
advantag
vlp
vaccin
present
multipl
viral
epitop
singl
particl
abil
effect
stimul
immun
respons
without
seriou
deleteri
effect
induc
live
attenu
viru
vaccin
addit
vlp
potenti
activ
endogen
exogen
antigen
process
pathway
lead
present
viral
peptid
major
histocompat
complex
mhc
class
ii
molecul
nevertheless
better
understand
replic
featur
viru
need
gener
vlp
vaccin
exampl
singl
inocul
vlp
vaccin
express
ha
protein
aiv
subtyp
elicit
high
level
hi
antibodi
lower
frequenc
viru
isol
challeng
virul
viru
indic
vlp
vaccin
would
promis
vaccin
candid
aiv
similarli
immun
vlp
vaccin
hpai
abl
protect
chicken
lethal
challeng
wild
type
hpai
viru
noninfecti
recombin
pentamerlik
structur
fmdv
gener
express
gene
protein
whose
express
control
individu
promot
baculoviru
express
system
structur
similar
authent
pentam
subunit
fmdv
electron
microscop
immun
vlp
mice
elicit
high
level
fmdv
specif
antibodi
swine
vesicular
diseas
viru
svdv
highli
contagi
diseas
pig
svdvlike
particl
gener
simultan
express
protein
svdv
resembl
antigen
morpholog
authent
viru
particl
vlp
may
use
vaccin
candid
svdv
orf
gene
clone
insert
baculoviru
express
system
recombin
protein
form
vlp
infect
insect
cell
attempt
creat
novel
vaccin
porcin
encephalomyocard
viru
emcv
caus
reproduct
failur
pregnant
sow
plasmid
contain
gene
emcv
gener
transfect
baculoviru
express
system
immun
vlp
mix
alum
adjuv
demonstr
induct
mainten
high
level
neutral
antibodi
led
high
protect
efficaci
challeng
wild
type
viru
prrsv
vlp
express
n
protein
gener
baculoviru
express
system
immun
mice
order
evalu
abil
induc
prrsvspecif
immun
respons
accord
unpublish
data
laboratori
prrsvvlp
elicit
strong
immun
respons
well
proper
neutral
antibodi
prrsv
suggest
vlp
repres
n
protein
would
potenti
vaccin
candid
prrsv
live
bacteri
vaccin
consist
small
quantiti
attenu
bacteria
elicit
good
immun
respons
similar
provok
natur
infect
although
attenu
bacteria
abl
infect
multipli
vaccin
host
longer
capabl
caus
clinic
diseas
result
impair
biolog
function
virul
determin
immun
reaction
deriv
vaccin
live
bacteria
last
longer
immun
gener
inactiv
bacteria
major
advantag
live
vaccin
broader
scope
durat
protect
anim
expos
stage
replic
bacteria
howev
critic
ensur
live
bacteri
vaccin
neither
underattenu
target
anim
wherea
underattenu
strain
may
pathogen
consequ
caus
natur
diseas
overattenu
would
elicit
enough
amount
immun
respons
effect
vaccin
sinc
live
bacteria
vaccin
elicit
good
level
humor
cellular
immun
properti
per
se
make
live
vaccin
highli
desir
creation
live
bacteri
vaccin
strain
follow
classic
method
would
achiev
conduct
multipl
passag
microorgan
suitabl
system
select
desir
mutant
method
readili
applic
target
pathogen
creat
attenu
vaccin
strain
howev
rel
littl
success
develop
attenu
bacteria
classic
method
reason
rel
mild
select
pressur
bacteria
vitro
passag
enabl
bacteria
temporarili
suppress
virul
determin
restart
express
determin
vivo
develop
vaccin
technic
feasibl
bacteria
due
lack
proper
tool
howev
current
advanc
genet
techniqu
make
practic
develop
attenu
strain
strategi
provid
opportun
creat
desir
mutant
variou
type
bacteria
manipul
target
gene
variou
genet
techniqu
includ
geneinsert
delet
disrupt
replac
point
mutat
best
target
bacteri
genom
gene
associ
virul
determin
biosynthesi
regulatori
gene
critic
bacteri
surviv
interestingli
standpoint
creat
vaccin
strain
delet
virulenceassoci
gene
bacteria
may
problemat
sinc
protect
immun
sometim
desir
virulenceassoci
protein
case
strain
provid
good
immun
vaccin
strain
chemic
alter
bacteri
vaccin
contain
modifi
bacteria
grown
media
supplement
proper
level
chemic
provok
mutat
bacteria
chang
abil
bacteria
caus
diseas
method
would
anoth
option
develop
weaken
bacteria
follow
proper
screen
method
suitabl
select
desir
mutant
altern
temperatur
sensit
mutant
gener
select
mutant
lost
abil
grow
anim
bodi
temperatur
grow
temperatur
present
ocular
nasal
caviti
gener
kill
vaccin
salmonella
abl
stimul
strong
immun
respons
offer
rel
low
degre
protect
compar
live
attenu
vaccin
also
difficult
appli
larg
flock
requir
lot
labor
vaccin
thu
live
form
attenu
salmonella
vaccin
effect
stimul
better
cellular
immun
iga
kill
vaccin
exampl
safeti
protect
efficaci
novel
cpxrlondelet
mutant
salmonella
speci
well
demonstr
chicken
piglet
includ
salmonella
enteritidi
strain
salmonella
gallinarum
strain
jol
salmonella
typhimurium
immunogen
viral
protein
display
surfac
vaccin
strain
salmonella
illustr
indic
bacteri
vector
may
deliveri
vehicl
repres
foreign
viral
protein
well
selfantigen
target
locat
induc
effect
immun
vaccin
host
addit
global
regul
ppgppdefect
mutant
gallinarum
serv
novel
vaccin
candid
abl
protect
chicken
challeng
wild
type
bacteria
salmonella
mutant
defect
ruvb
gene
encod
holliday
junction
helicas
show
signific
impair
cell
surviv
prolifer
within
epitheli
cell
macrophag
ruvb
mutant
confer
strong
durabl
immunebas
protect
challeng
virul
strain
typhimurium
mutant
might
novel
live
vaccin
sinc
abil
induc
protect
immun
without
caus
clinic
manifest
porcin
prolif
enteropathi
ppe
caus
oblig
intracellular
bacteria
lawsonia
intracellulari
whose
virul
immunolog
activ
larg
known
vaccin
ppe
prepar
attenu
strain
deriv
clinic
isol
serial
pass
cell
cultur
phenotyp
genet
featur
licens
vaccin
strain
differenti
field
strain
vaccin
oral
administ
vaccin
shed
host
induc
immun
respons
slightli
howev
shed
challeng
strain
fece
vaccin
reduc
show
increas
growth
perform
compar
unvaccin
pig
kill
vaccin
prepar
cultur
bacteria
collect
cell
inactiv
suitabl
mean
heat
treatment
chemic
procedur
destroy
abil
pathogen
replic
host
keep
intact
immunolog
sinc
vaccin
undergo
purif
antigen
immun
vaccin
would
induc
virtual
compon
bacteria
antibodi
would
neutral
pathogen
best
advantag
kill
vaccin
safeti
opportun
kill
vaccin
revert
virul
one
capabl
caus
diseas
due
composit
complet
inactiv
bacteria
howev
kill
vaccin
tend
provid
shorter
length
protect
live
vaccin
booster
need
creat
long
term
immun
interestingli
b
subunit
cholera
toxin
lack
toxin
activ
express
purifi
ad
bacteria
protein
recombin
vaccin
somewhat
higher
efficaci
recent
studi
shown
use
tetanu
toxoid
vaccin
antigen
subcutan
immun
issodd
conjug
cholera
toxin
b
markedli
enhanc
antigen
specif
igg
antibodi
respons
alter
specif
pattern
antibodi
toward
respons
subunit
vaccin
usual
contain
part
target
pathogen
immun
respons
would
compon
vaccin
achiev
isol
particular
immunogen
protein
pathogen
present
antigen
strategi
would
prefer
mani
type
pathogen
reli
sever
techniqu
includ
genet
biochemistri
molecular
biolog
identifi
proper
antigen
epitop
correspond
peptid
candid
vaccin
antigen
antigen
deriv
bacteri
surfac
compon
clone
express
purifi
protect
potenti
assess
anim
infect
model
past
decad
modern
genet
techniqu
enabl
easili
identif
vaccin
antigen
lieu
previou
avail
biochem
antigen
data
use
compil
genet
inform
pathogen
sequenc
analysi
complet
genom
mani
bacteria
result
identif
novel
candid
vaccin
antigen
base
structur
biochem
featur
hydrophob
homolog
vaccin
antigen
relat
pathogen
gene
express
use
foreign
protein
express
system
includ
escherichia
coli
yeast
insect
mammalian
cell
purifi
inject
host
elicit
immun
result
product
combin
proper
adjuv
use
subunit
recombin
vaccin
vaccin
benefit
due
inabl
replic
host
well
toler
due
addit
good
purif
step
given
broad
rang
avail
approach
feasibl
produc
subunit
vaccin
variou
type
pathogen
immunogen
subunit
vaccin
may
purifi
protein
peptid
polysaccharid
sinc
antigen
alon
weak
immunogen
immun
establish
vaccin
may
enhanc
administr
potent
adjuv
welldefin
deliveri
system
gener
multipl
dose
vaccin
need
attain
satisfactori
immunolog
respons
subunit
vaccin
certain
case
administr
vaccin
appropri
adjuv
enabl
induct
cellmedi
immun
use
prevent
diseas
caus
bacteria
grow
intracellularli
exampl
outer
membran
protein
h
omph
pasteurella
multocida
signific
similar
primari
secondari
serotyp
recombin
omph
protein
express
e
coli
antigen
show
strong
protect
p
multocida
infect
omph
might
use
vaccin
candid
antigen
p
multocida
recombin
protein
contain
middlectermin
region
p
multocida
toxin
pmt
express
e
coli
induc
high
titer
pmtspecif
antibodi
show
effect
protect
homolog
challeng
mice
heatlabil
toxin
b
subunit
ltb
enterotoxigen
e
coli
etec
use
adjuv
carrier
fuse
protein
antigen
immun
recombin
ltb
protein
produc
transgen
rice
callu
induc
humor
secretori
antibodi
immun
respons
indic
ltb
protein
plantbas
edibl
vaccin
candid
etec
number
speci
live
bacteria
use
vaccin
carrier
enabl
deliveri
clone
vaccin
antigen
enter
intrans
enter
bacteria
speci
abil
colon
intestin
mucosa
particular
mucosaassoci
lymphoid
tissu
main
point
invas
enter
bacteria
howev
realiti
applic
type
vaccin
complic
less
effici
due
low
level
express
insert
protein
antigen
less
effici
transloc
surfac
bacteria
protect
antigen
display
addit
immun
respons
clone
antigen
often
much
weaker
respons
carrier
protein
origin
anoth
issu
level
immun
respons
carrier
may
preclud
futur
use
either
display
deliv
foreign
protein
purpos
bacteri
gene
respons
virul
colon
surviv
modul
gene
express
delet
vivo
desir
remov
independ
gene
genet
loci
contribut
virul
order
assur
attenu
bacteri
carrier
reduc
possibl
revers
anoth
strategi
creat
mutant
chemic
alter
strain
salmonella
deriv
fashion
licens
prevent
typhoid
fever
goal
creat
carrier
vector
present
foreign
antigen
immun
system
context
live
bacteri
infect
host
immun
system
recogn
antigen
naturalform
immunogen
therebi
develop
broader
immun
correspond
pathogen
antigen
express
carrier
vector
transport
cell
surfac
stimul
antibodi
product
cytoplasm
pathway
elicit
cytotox
lymphocyt
respons
howev
major
bacteria
infect
cell
recombin
antigen
express
bacteri
surfac
peptid
would
elicit
product
antibodi
engin
enter
pathogen
commonli
use
purpos
induc
mucos
immun
foreign
polypeptid
upon
oral
deliveri
field
live
bacteria
vector
attenu
salmonella
carrier
oral
deliveri
vector
use
malaria
anthrax
cholera
challeng
issu
creat
carrier
vaccin
vaccin
strain
retain
suffici
abil
replic
gut
attenu
enough
pathogen
howev
abil
express
appropri
level
foreign
protein
interestingli
abil
certain
bacteria
replic
intracellularli
may
augment
abil
express
foreign
peptid
within
cell
consequ
elicit
cellular
immun
correspond
pathogen
attenu
salmonella
cross
intestin
wall
deliv
express
antigen
activ
pathway
innat
immun
intestin
immun
tissu
anoth
vector
strain
employ
commens
bacteria
present
foreign
antigen
sinc
strain
natur
colon
without
induc
clinic
sign
abl
persist
year
bodi
compart
exampl
fusion
protein
contain
viral
antigen
express
surfac
oral
vaccin
strain
typhimurium
inocul
intrans
intraperiton
mice
bacteri
carrier
vaccin
induc
mucos
system
immun
multipl
viral
antigen
thu
vaccin
strain
salmonella
play
signific
role
deliv
foreign
vaccin
protein
virulenceassoci
gene
fasa
intimin
pathogen
e
coli
individu
clone
attenu
typhimurium
recombin
strain
inject
mice
detect
fecal
sampl
highli
immunogen
etec
respons
common
enter
colibacillosi
piglet
fimbria
known
specif
adhes
factor
associ
colon
etec
small
intestin
recombin
lactobacillu
acidophilu
express
recombin
e
coli
fimbria
show
signific
inhibitori
effect
e
coli
consequ
prevent
e
coli
bind
intestin
brush
border
evalu
effect
swine
immun
modul
kill
vaccin
attenu
typhimurium
express
construct
oral
administr
pig
prior
vaccin
inactiv
pseudorabi
vaccin
pig
receiv
recombin
salmonella
elicit
enhanc
level
pseudorabiesspecif
igg
compar
control
group
addit
immun
respons
rapidli
elev
render
piglet
display
allevi
clinic
sign
follow
challeng
virul
pseudorabi
viru
prrsv
recombin
attenu
typhimurium
express
protein
prrsv
construct
immun
mice
evalu
capabl
induc
immun
respons
prrsv
follow
oral
administr
singl
dose
recombin
salmonella
humor
cellmedi
immun
induc
system
mucos
site
sustain
least
week
postimmun
conjug
vaccin
somewhat
similar
recombin
subunit
vaccin
usual
compos
two
differ
compon
gener
pathogen
whose
polysaccharid
capsul
protect
phagocytosi
sinc
polysaccharid
poorli
immunogen
link
polysaccharid
immunogen
protein
enabl
immun
system
recogn
protein
antigen
produc
chemic
link
polysaccharid
carrier
protein
creat
stronger
combin
immun
respons
piec
deriv
bacteria
well
carrier
protein
immun
piec
bacteria
protect
futur
infect
type
vaccin
current
use
streptococcu
pneumonia
contrast
bacteri
diseas
directli
caus
bacteria
toxin
produc
bacteria
tetanu
caus
neurotoxin
produc
clostridium
tetani
rather
bacteri
infect
vaccin
type
pathogen
gener
inactiv
toxin
respons
caus
clinic
sign
pathogen
use
kill
vaccin
inactiv
process
perform
via
treatment
heat
chemic
suitabl
mean
although
inactiv
toxin
could
consid
kill
vaccin
sometim
categori
highlight
contain
inactiv
toxin
bacteria
exampl
conjug
vaccin
compos
vi
capsular
polysaccharid
typi
conjug
diphtheria
toxoid
gener
inocul
mice
order
valid
immunogen
immun
singl
dose
conjug
induc
high
titer
igg
wherea
inocul
larg
amount
unconjug
polysaccharid
alon
show
suppress
antibodi
capsular
polysaccharid
pneumonia
conjug
cholera
toxin
b
subunit
evok
mucos
system
immun
respons
immun
via
either
periton
intranas
rout
although
develop
anim
vaccin
past
mainli
focus
control
infecti
diseas
anim
current
statu
develop
effect
vaccin
reduc
foodborn
pathogen
load
livestock
highlight
section
intervent
strategi
anim
vaccin
also
use
reduc
risk
transmit
zoonot
agent
industri
anim
human
consumpt
meat
product
demand
food
product
includ
meat
drastic
increas
suppli
rapidli
grow
popul
worldwid
result
increas
popul
industri
anim
larg
number
industri
anim
rais
small
region
great
chanc
infecti
diseas
includ
zoonot
agent
strike
particular
pathogen
capabl
establish
within
industri
anim
without
harm
clinic
sign
sometim
becom
infecti
human
caus
ill
type
zoonot
agent
caus
clinic
sign
industri
anim
human
transmit
human
via
food
consumpt
caus
zoonot
ill
human
recent
strict
regul
use
antimicrobi
anim
feed
establish
order
avoid
emerg
issu
antibiot
resist
could
caus
problemat
issu
human
futur
antibiot
resist
within
normal
flora
industri
anim
overus
antibiot
transfer
zoonot
agent
eventu
human
current
sensit
issu
anim
industri
condit
effect
vaccin
zoonot
pathogen
industri
anim
may
help
resolv
public
health
concern
basi
recent
report
emerg
infecti
diseas
zoonot
indic
effect
mean
control
diseas
would
great
valu
gener
modern
vaccin
zoonot
agent
industri
anim
marker
vaccin
industri
would
use
massiv
result
immun
could
differenti
measur
companion
diagnost
method
marker
vaccin
interfer
current
diagnost
procedur
vaccin
anim
certainli
help
control
zoonot
diseas
develop
specif
diagnost
method
replac
current
test
allow
develop
live
kill
vaccin
variou
vaccin
shown
limit
effect
reduc
transmiss
zoonot
agent
human
consumpt
animalderiv
product
note
certain
gener
procedur
appli
prevent
establish
zoonot
agent
livestock
keep
anim
free
infect
prevent
contact
potenti
infect
anim
maintain
clean
hous
food
nevertheless
research
requir
develop
complementari
vaccin
sanit
program
protect
human
zoonot
infect
present
section
focus
anim
vaccin
select
zoonot
agent
econom
signific
industri
anim
among
enter
bacteria
frequent
present
e
coli
deadli
bacteria
often
present
gut
fece
skin
healthi
cattl
sheep
bacteria
well
adapt
host
without
show
evid
clinic
sign
bacteria
surviv
coupl
month
variou
environ
condit
could
transmit
human
via
food
notabl
cook
ground
beef
raw
milk
human
outbreak
associ
hemolyt
urem
syndrom
sever
consequ
among
small
percentag
case
although
variou
intervent
strategi
introduc
feedlot
us
strict
hygien
measur
account
declin
outbreak
recent
subunit
vaccin
contain
secret
virul
factor
test
field
feedlot
cattl
result
still
far
clearanc
bacteria
clearli
vaccin
could
aid
futur
reduct
number
outbreak
combin
hygien
measur
among
mani
serotyp
salmonella
speci
clinic
salmonellosi
industri
anim
result
infect
hostrestrict
serotyp
salmonella
enter
gallinarum
dublin
pullorum
sometim
nonhost
specif
salmonella
serotyp
sometim
induc
selflimit
gastrointestin
infect
caus
system
infect
wide
varieti
host
anim
includ
human
among
salmonella
spp
typhimurium
enteritidi
two
serotyp
commonli
associ
foodborn
diseas
human
mostli
occur
asymptomat
livestock
poultri
variou
kill
live
vaccin
commerci
avail
swine
typhimurium
infect
mostli
subclin
transfer
meat
product
human
sever
vaccin
swine
shown
effect
interfer
homolog
heterolog
serotyp
vaccin
livestock
consid
one
cornerston
strategi
reduc
human
salmonella
infect
gener
protect
salmonella
requir
cellular
immun
well
particular
local
mucos
immun
gastrointestin
tract
prevent
colon
gut
elimin
bacteria
cross
contamin
problem
meat
process
slaughter
hous
would
challeng
task
variou
success
case
report
point
attenu
live
vaccin
recogn
effect
reduc
fecal
shed
salmonella
vaccin
campylobact
jejuni
major
caus
foodborn
diseas
human
consumpt
contamin
meat
product
particular
poultri
bacterium
well
adapt
chicken
low
infecti
dose
human
chicken
bacteria
heavili
persist
colon
gut
without
evid
clinic
sign
lack
pathogen
interact
host
challeng
issu
develop
reliabl
vaccin
addit
heterolog
genet
antigen
result
uptak
foreign
dna
abil
natur
compet
mani
type
live
inactiv
vaccin
test
practic
applic
vaccin
contain
whole
bacteria
flagellin
provid
partial
protect
campylobact
challeng
chicken
howev
attenu
live
vaccin
may
promis
near
futur
although
sever
vaccin
develop
prevent
human
infect
vaccin
chicken
would
better
way
prevent
transmiss
human
ultim
implement
rigor
hygien
measur
carcass
slaughter
would
best
way
control
bacteria
brucellosi
major
zoonot
diseas
threat
human
anim
develop
countri
brucella
infect
livestock
result
abort
weak
offspr
longterm
fertil
problem
mani
develop
countri
test
slaughter
strategi
effect
adapt
erad
diseas
vaccin
provid
consider
level
protect
limit
outcom
prevent
brucellosi
thu
far
attenu
live
vaccin
success
wide
use
cattl
recent
vaccin
base
stabl
rough
mutant
b
abortu
strain
use
mani
countri
includ
us
human
infect
usual
occur
consumpt
unpasteur
milk
sinc
cellular
immun
requir
longterm
protect
best
result
obtain
live
attenu
vaccin
vaccin
also
work
herd
adult
anim
lower
dose
use
prevent
abort
interfer
serolog
diagnost
test
recent
rough
strain
reduc
oantigen
express
develop
use
us
sinc
gener
speak
none
avail
brucella
vaccin
give
steril
protect
best
way
control
brucellosi
success
use
hygien
measur
well
spell
specif
protocol
product
research
vaccin
brucella
conduct
korea
vaccin
strategi
abolish
continu
polici
test
slaughter
lead
lower
preval
earli
industri
anim
import
vehicl
sever
foodborn
pathogen
mainli
enter
bacteria
often
asymptomat
carri
anim
intestin
tract
major
sourc
contamin
animalderiv
food
product
varieti
intervent
strategi
reduc
foodborn
pathogen
load
product
develop
appli
variou
stage
food
product
howev
best
way
reduc
pathogen
load
like
requir
applic
combin
variou
intervent
strategi
vaccin
proven
costeffect
mean
prevent
infecti
diseas
erad
infecti
agent
state
articl
use
vaccin
industri
anim
greatli
influenc
anim
health
welfar
product
industri
anim
eventu
contribut
food
safeti
despit
excel
illustr
vaccin
effect
variou
pathogen
develop
anim
vaccin
recogn
challeng
task
due
presenc
varieti
anim
type
infecti
agent
differ
pathogen
mechan
pathogen
case
anim
scientist
contribut
develop
human
vaccin
provid
research
result
obtain
experiment
anim
well
attempt
new
trial
anim
less
restrict
human
trial
due
similar
size
anatomi
human
larg
anim
particular
pig
use
test
vaccin
efficaci
vaccin
deliveri
system
ultim
goal
anim
vaccin
provid
effici
protect
variou
anim
infecti
agent
reason
develop
anim
vaccin
achiev
multidisciplinari
collabor
includ
microbiolog
immunolog
proteom
genet
molecular
biolog
even
bioinformat
although
expect
elicit
immun
respons
protect
wild
type
infect
vaccin
may
abl
complet
prevent
natur
infect
might
reduc
sever
diseas
sometim
vaccin
fail
execut
improp
time
high
level
preexist
antibodi
malnutrit
environ
extrem
stress
condit
result
advers
effect
poor
immun
respons
anoth
factor
vaccin
contain
proper
immunogen
antigen
effect
therefor
correct
vaccin
select
appli
proper
time
advers
effect
deriv
vaccin
minim
well
accept
cost
vaccin
less
econom
loss
induc
natur
infect
addit
order
effect
cope
treatment
variou
infecti
agent
vaccin
use
anim
mutual
exchang
inform
among
practition
farmer
diseas
control
agenc
particular
mani
manag
procedur
extrem
import
relat
excel
outcom
vaccinationanim
densiti
environment
control
level
stress
cleanli
environ
drink
water
develop
procedur
anim
vaccin
still
reli
classic
strategi
live
pathogen
possess
strong
immunogen
either
high
virul
without
virul
howev
decad
great
acceler
advanc
modern
molecular
techniqu
compil
genom
data
mani
pathogen
advanc
provid
great
opportun
creat
desir
vaccin
strain
less
danger
effect
immunogen
vaccin
achiev
classic
method
well
establish
immun
system
sever
effector
mechan
cope
variou
pathogen
would
depend
lifecycl
microenviron
infect
host
sinc
kill
vaccin
still
mainli
use
livestock
absolut
necessari
develop
novel
adjuv
order
enhanc
satisfactori
immun
vaccin
potent
adjuv
abl
effect
elicit
cellular
immun
anim
vaccin
less
immunogen
vaccin
includ
kill
subunit
vaccin
way
resolv
issu
would
develop
new
deliveri
system
plasmid
dna
liposom
microparticl
live
viral
bacteri
vector
introduc
vaccin
antigen
intracellular
compart
anoth
notabl
advanc
immunolog
increas
recognit
major
role
innat
immun
vaccin
adjuv
function
often
ignor
despit
signific
influenc
vaccin
develop
recent
discov
innat
immun
receptor
screen
new
adjuv
materi
activ
use
induc
enhanc
vaccin
reaction
current
mani
type
adjuv
use
anim
vaccin
commerci
vaccin
product
fulfil
regul
vaccin
efficaci
safeti
develop
process
instruct
govern
us
anim
vaccin
come
unit
state
depart
agricultur
usda
regul
korea
anim
vaccin
regul
anim
plant
fisheri
quarantin
inspect
agenc
eu
regul
control
law
eu
regulatori
agenc
take
account
faster
lower
cost
rout
registr
human
vaccin
consider
commerci
market
overal
demand
anim
vaccin
steadili
grow
due
fast
increas
livestock
popul
overal
along
less
stringent
regulatori
requir
research
develop
anim
vaccin
would
forefront
experiment
trial
innov
techniqu
commerci
opportun
